Moderna, Inc. 2022 Q4 - Results - Earnings Call Presentation

06:05pm, Thursday, 24'th Feb 2022 Seeking Alpha
Moderna Chief Medical Officer Paul Burton said Covid is entering an endemic phase in the northern hemisphere.
Moderna Inc. (NASDAQ: MRNA ) shares are trading after the company reported better-than-expected fourth-quarter EPS and sales results and announced a new $3 billion buyback. Moderna reported quarterly earnings of $11.29 per share, beating the analyst consensus estimate of $9.90. The company reported quarterly sales of $7.20 billion, beating the analyst consensus estimate of $6.79 billion Moderna is up 9.3% at $148.41 at time of publication. Related: What''s Going On With Moderna Shares Today? Moderna Daily Chart Analysis the stock has trended lower throughout the past couple of months, falling below the higher low trendline in what traders call an ascending triangle pattern. The stock … Full story available on Benzinga.com
The company''s vaccine sales are predicted to reach $20.72 billion in 2022.

Why Moderna Stock Is Surging Higher Today

05:32pm, Thursday, 24'th Feb 2022 The Motley Fool
The biotech''s latest earnings report is giving investors a reason to cheer today.
Moderna increased its vaccine sales forecasts after beating Q4 earnings expectations.

Moderna Stock Surges On Q4 Earnings Beat, 2022 Vaccine Sales Boost

03:19pm, Thursday, 24'th Feb 2022 Bitcoin Ethereum News
The post Moderna Stock Surges On Q4 Earnings Beat, 2022 Vaccine Sales Boost appeared on BitcoinEthereumNews.com . Updated at 10:06 am EST Moderna (MRNA) – Get Moderna, Inc. Report shares surged Thursday after the drugmaker posted must stronger-than-expected fourth quarter earnings, while boosting its full-year sales forecast for…
U.S. stocks opened on a downbeat note this morning after Russia’s President Vladimir Putin announced that the country’s armed forces would carry out a “special military operation” in Ukraine. Following the market opening Thursday, the Dow traded down 1.99% to 32,473.96 while the NASDAQ fell 1.34% to 12,862.96. The S&P also fell, dropping, 1.51% to 4,161.87. Check out this: Insiders Buy More Than $170M Of 4 Stocks Leading and Lagging Sectors Utilities shares slipped by just 0.4% on Thursday. Meanwhile, top gainers in the sector included South Jersey Industries, Inc. (NYSE: SJI ), up 40% and Sunnova Energy International Inc. (NYSE: NOVA ) up 3%. In trading on Thursday, financials shares dipped 3%. Top Headline Moderna, Inc. (NASDAQ: MRNA ) reported better-than-expected results for its fourth quarter and announces a new $3 billion buyback program. Moderna posted quarterly earnings of $11.29 per share, beating analysts’ estimates of $9.90 per share. The company’s quarterly sales came in at $7.20 billion, versus expectations of $6.79 billion.

Moderna says it expects almost $20 billion in COVID-19 vaccine sales in 2022

03:04pm, Thursday, 24'th Feb 2022 United Press International
Biotech company Moderna said Thursday that it expects to make almost $20 billion this year from sales of its COVID-19 vaccine -- the only product that it has on the market.

Moderna Earnings: What Happened with MRNA

01:35pm, Thursday, 24'th Feb 2022 Investopedia
Moderna''s (MRNA) Q4 earnings and revenue exceeded analysts'' expectations. The company announced a new share repurchase program.

Covid vaccine sales push Moderna to $12-bn profit in 2021

01:19pm, Thursday, 24'th Feb 2022 Business Standard
The vaccine maker''s COVID-19 shots, which are now available in more than 70 countries, totalled USD 17.7 billion in sales last year, their first full year on the market

Covid vaccine sales push Moderna to $12B profit in 2021

01:15pm, Thursday, 24'th Feb 2022 TribLIVE
Moderna’s covid-19 vaccine brought in nearly $7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase agreements for another $19 billion in sales this year.

COVID-19 vaccine sales push Moderna to US$12B profit in 2021

01:09pm, Thursday, 24'th Feb 2022 CTV News
Moderna''s COVID-19 vaccine brought in nearly US$7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase agreements for another US$19 billion in sales this year.
Moderna Inc (NASDAQ: MRNA ) reports a Q4 EPS of $11.29 , a turnaround from an EPS loss of $(0.69) a year ago, beating the consensus estimate of $9.90. The Company clocked Q4 revenues of $7.21 billion compared to just $571 million a year ago, beating the consensus of $6.79 billion. Product sales were $6.9 billion from sales of 297 million doses of … Full story available on Benzinga.com
Global Stocks, Futures Crash; Nasdaq In Bear Market, Oil Soars Above $105 On Russia Attack U.S. stock index futures crashed along with global markets on Thursday as Russia’s assault on Ukraine sent investors fleeing risky assets, while the tech-heavy Nasdaq was set to open in a bear market. Contracts on the Nasdaq 100 were down 2.9% by 7 a.m. in New York, having dropped as much as 3.6% earlier and signaling that the underlying gauge was poised to fall 20% from its November record high for the first time since the pandemic; the S&P 500 was down 2.23% or 98 points to, 4,214, while Dow futures lost 2.3%. The flight to safety saw the 10-year Treasury yield tumble 14 basis points to under 1.9%. Gold hit the highest since September 2020, while the dollar also spiked higher. The Nasdaq was set to open in a bear market, with NQ futures down more than 20% from its all time highs just two months ago… ... while the VIX spiked higher, and was last just around 37, up almost 10 points on the day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE